CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients Systems of Care for ST-Segment–Elevation Myocardial Infarction: A Policy Statement From the American Heart Association Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond Evaluation and Management of Nonculprit Lesions in STEMI Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative Percutaneous Support Devices for Percutaneous Coronary Intervention Association of Cardiovascular Disease With Respiratory Disease Reappraisal of Reported Genes for Sudden Arrhythmic Death: An Evidence-Based Evaluation of Gene Validity for Brugada Syndrome

Original Research2019 Jul;12(7):e005103.

JOURNAL:Circ Cardiovasc Qual Outcomes. Article Link

Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients

Shavadia JS, Holmes DN, Thomas L et al. Keywords: 3-year post-MI survivors; β-blocker; elderly; observational study; long-term cardiovascular outcomes

FULL TEXT PDF